Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?

Barrera F, George J.

Hepatology. 2014 Jan;59(1):16-8. doi: 10.1002/hep.26588. Epub 2013 Nov 19. No abstract available.

PMID:
23787943
[PubMed - indexed for MEDLINE]
2.

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Verrijken A, Francque S, Mertens I, Prawitt J, Caron S, Hubens G, Van Marck E, Staels B, Michielsen P, Van Gaal L.

Hepatology. 2014 Jan;59(1):121-9. doi: 10.1002/hep.26510. Epub 2013 Nov 8.

PMID:
24375485
[PubMed - indexed for MEDLINE]
3.

[Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].

Graffigna MN, Belli SH, de Larrañaga G, Fainboim H, Estepo C, Peres S, García N, Levalle O.

Acta Gastroenterol Latinoam. 2009 Mar;39(1):30-7. Spanish.

PMID:
19408737
[PubMed - indexed for MEDLINE]
4.

Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome.

de Larrañaga G, Wingeyer SP, Graffigna M, Belli S, Bendezú K, Alvarez S, Levalle O, Fainboim H.

Clin Appl Thromb Hemost. 2008 Jul;14(3):319-24. Epub 2007 Dec 26.

PMID:
18160600
[PubMed - indexed for MEDLINE]
5.

Nonalcoholic fatty liver disease and cardiovascular risk: is there a place for obstructive sleep apnea?

Mirrakhimov AE, Mirrakhimov EM.

Can J Cardiol. 2013 Sep;29(9):1139.e7. doi: 10.1016/j.cjca.2012.10.019. Epub 2012 Dec 21. No abstract available.

PMID:
23265092
[PubMed - indexed for MEDLINE]
6.

Reply to Mirrakhimov and Mirrakhimov--nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.

Alp H.

Can J Cardiol. 2013 Sep;29(9):1139.e9. doi: 10.1016/j.cjca.2012.11.011. Epub 2013 Jan 24. No abstract available.

PMID:
23352427
[PubMed - indexed for MEDLINE]
7.

Infantile obesity: a situation of atherothrombotic risk?

Valle M, Gascón F, Martos R, Ruz FJ, Bermudo F, Ríos R, Cañete R.

Metabolism. 2000 May;49(5):672-5.

PMID:
10831182
[PubMed - indexed for MEDLINE]
8.

[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].

Choi SY, Kim D, Kang JH, Park MJ, Kim YS, Lim SH, Kim CH, Lee HS.

Korean J Hepatol. 2008 Mar;14(1):77-88. doi: 10.3350/kjhep.2008.14.1.77. Korean.

PMID:
18367860
[PubMed - indexed for MEDLINE]
Free Article
9.

Nonalcoholic fatty liver disease and cardiovascular disease risk.

Schindhelm RK, Diamant M, Heine RJ.

Curr Diab Rep. 2007 Jun;7(3):181-7. Review.

PMID:
17547835
[PubMed - indexed for MEDLINE]
10.

Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children.

Alisi A, Manco M, Devito R, Piemonte F, Nobili V.

J Pediatr Gastroenterol Nutr. 2010 Jun;50(6):645-9. doi: 10.1097/MPG.0b013e3181c7bdf1.

PMID:
20400911
[PubMed - indexed for MEDLINE]
11.

Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs.

Kaye SM, Pietiläinen KH, Kotronen A, Joutsi-Korhonen L, Kaprio J, Yki-Järvinen H, Silveira A, Hamsten A, Lassila R, Rissanen A.

Obesity (Silver Spring). 2012 Jan;20(1):88-94. doi: 10.1038/oby.2011.287. Epub 2011 Sep 29.

PMID:
21959347
[PubMed - indexed for MEDLINE]
12.

Role of fibrinolysis in obesity and thrombosis.

Lijnen HR.

Thromb Res. 2009;123 Suppl 4:S46-9. doi: 10.1016/S0049-3848(09)70143-4. Review.

PMID:
19303504
[PubMed - indexed for MEDLINE]
13.

Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis.

Targher G, Bertolini L, Scala L, Zenari L, Lippi G, Franchini M, Arcaro G.

Diabetes Care. 2007 May;30(5):e31-2. No abstract available.

PMID:
17468361
[PubMed - indexed for MEDLINE]
14.

Obesity and hepatocellular carcinoma.

Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103. Review.

PMID:
15508109
[PubMed - indexed for MEDLINE]
15.

[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease].

Kim MY, Baik SK.

Korean J Hepatol. 2008 Mar;14(1):1-3. doi: 10.3350/kjhep.2008.14.1.1. Korean. No abstract available.

PMID:
18367852
[PubMed - indexed for MEDLINE]
Free Article
16.

Nonalcoholic fatty liver disease and obesity.

Salgado Júnior W, Santos JS, Sankarankutty AK, Silva Ode C.

Acta Cir Bras. 2006;21 Suppl 1:72-8. Review.

PMID:
17013519
[PubMed - indexed for MEDLINE]
Free Article
17.

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I.

J Nutr. 2008 Aug;138(8):1452-5.

PMID:
18641190
[PubMed - indexed for MEDLINE]
Free Article
18.

[The association of cardiovascular risk factors with nonalcoholic fatty liver disease in health checkup examinees].

Yu JH, Lee KS, Lee SY, Hong AR, Park YS.

J Prev Med Public Health. 2008 Nov;41(6):407-12. doi: 10.3961/jpmph.2008.41.6.407. Korean.

PMID:
19037170
[PubMed - indexed for MEDLINE]
Free Article
19.

Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.

Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M.

Semin Thromb Hemost. 2009 Apr;35(3):277-87. doi: 10.1055/s-0029-1222606. Epub 2009 May 18. Review.

PMID:
19452403
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk